Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Cash flows from operating activities
Net income	$ 101,112	$ 96,938
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,123	14,378
Amortization of deferred financing fees	187	162
Equity-based compensation	11,213	10,943
Deferred taxes	(596)	(1,919)
Loss on disposal of property, plant, and equipment	57	96
Foreign currency transaction (gain) loss	(70)	76
Equity in net loss of affiliates	2,034	0
Dividends from equity method investment	766	0
Change in fair value of contingent consideration	7,912	0
Change in assets and liabilities:
Accounts receivable	(10,051)	12,101
Floor plan receivables	(15,155)	(2,521)
Inventories	(6,759)	20,059
Other assets	(330)	(13,434)
Accounts payable	13,895	4,387
Accrued expenses and other liabilities	20,104	(12,128)
Net cash provided by operating activities	144,442	129,138
Cash flows from investing activities
Additions to property, plant, and equipment	(24,827)	(22,847)
Cash paid for equity method investment	0	(1,000)
Cash paid for investment in ECN common stock	0	(78,858)
Cash paid for investment in ECN preferred stock	0	(64,520)
Investment in floor plan loans	0	(18,466)
Proceeds from floor plan loans	2,136	10,528
Proceeds from disposal of property, plant, and equipment	138	524
Net cash used in investing activities	(22,553)	(174,639)
Cash flows from financing activities
Changes in floor plan financing, net	(5,308)	0
Payments on long term debt	(11)	0
Payments on repurchase of common stock	(40,000)	0
Stock option exercises	272	224
Tax payments for equity-based compensation	(2,273)	(982)
Net cash used in financing activities	(47,320)	(758)
Effect of exchange rate changes on cash and cash equivalents	599	(39)
Net increase (decrease) in cash and cash equivalents	75,168	(46,298)
Cash and cash equivalents at beginning of period	495,063	747,453
Cash and cash equivalents at end of period	$ 570,231	$ 701,155